| Date Filed | Type | Description |
| 07/06/2023 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 3,192 shares
@ $89.4109, valued at
$285.4k
Sold 3,287 shares
@ $90.4165, valued at
$297.2k
Sold 300 shares
@ $91.0983, valued at
$27.3k
Exercised 6,779 options to buy
@ $10.03, valued at
$68k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 1,600 shares
@ $90.6044, valued at
$145k
Sold 30,609 shares
@ $87.7886, valued at
$2.7M
Sold 7,064 shares
@ $88.3649, valued at
$624.2k
Sold 30,506 shares
@ $89.8259, valued at
$2.7M
Exercised 69,779 options to buy
@ $10.03, valued at
$699.9k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 11,683 shares
@ $0
Paid exercise price by delivering 974 shares
@ $58.5, valued at
$57k
Granted 16,572 options to buy
@ $35.46, valued at
$587.6k
|
|
| 02/14/2023 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 975 shares
@ $51.21, valued at
$49.9k
|
|
| 01/30/2023 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 551 shares
@ $52.77, valued at
$29.1k
|
|
| 01/24/2023 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,379 shares
@ $52.05, valued at
$123.8k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 650 shares
@ $38.59, valued at
$25.1k
|
|
| 01/25/2022 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 30,787 shares
@ $0
Granted 43,670 options to buy
@ $35.46, valued at
$1.5M
|
|
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2019 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 11,699 shares
@ $29.7145, valued at
$347.6k
|
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2018 |
4
| Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $14.95, valued at
$373.8k
|
|
| 11/08/2017 |
3
| Sullivan Timothy Eugene (CFO) has filed a Form 3 on Apellis Pharmaceuticals, Inc. |
| 05/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |